LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

Gestermann, Nicolas Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland
Saugy, Damien Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland
Martignier, Christophe Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland
Tillé, Laure Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland
Fuertes Marraco, Silvia A. Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland
Zettl, Markus Boehringer Ingelheim RCV GmbH & CoKG, Vienna, Austria
Tirapu, Iñigo Boehringer Ingelheim RCV GmbH & CoKG, Vienna, Austria
Speiser, Daniel E. Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Ontario Cancer Institute, Toronto, Canada
Verdeil, Grégory ORCID Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland